EUVIMEDEUVIMED entdecken
Open Access

The Impact of Combretastatin A-4 on Cancer Cells and Circulating Tumor Cells (CTCs): A Multi-Assay Approach

Dimitrios Papakonstantinou, Vasileios Vardas, Despoina M Varouhaki, Aikaterini Kotzamouratoglou, Karolina Mangani, Julia A Ju, Catherine Alix-Panabières, Stuart S Martin, Constantinos M Athanassopoulos, Galatea Kallergi

Oncology Research · 2026

DOI: 10.32604/or.2026.085665 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Research, 2026. Verfasst von Dimitrios Papakonstantinou und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Biochemistry/Metastatic Signaling, Section of Genetics, Cell Biology and Development, Department of Biology, University of Patras, Univ…. Hauptthemen laut MEDLINE: Neoplastic Cells, Circulating, Stilbenes, Antineoplastic Agents, Phytogenic, Neoplasms. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Combretastatin A-4 (CA-4) is a microtubule-disrupting agent with established anti-tumor properties. This study aimed to evaluate the effects of CA-4 on key metastatic traits of cancer cells, including migration, clonogenic potential, cytoskeletal protein expression, and microtentacle (McTN) formation, using multiple cancer cell models, including the colon patient-derived circulating tumor cell line CTC-MCC-41.

Methods

H1299 (non-small cell lung cancer), MDA-MB-231 (triple-negative breast cancer), HT-29 (colorectal cancer), and CTC-MCC-41 (derived from the blood of a colon cancer patient) cells were treated with CA-4 (10 μM) for 24 and 48 h. Colony formation was assessed with a clonogenic assay. Migration assays (Boyden chamber) evaluated cell motility, while cell viability was determined via MTT assay. Western blot analysis examined vimentin and α/β-tubulin expression. TetherChip assay analyzed McTN formation using wheat germ agglutinin (WGA) staining.

Results

CA-4 treatment significantly reduced cell viability, colony formation, and migration across all tested cancer cell lines. Western blot analysis revealed a marked reduction in vimentin and α/β-tubulin expression after 48 h of treatment, indicating disruption of cytoskeletal integrity. In addition, TetherChip analysis demonstrated a pronounced decrease in McTN formation following CA-4 exposure, suggesting inhibition of cytoskeletal protrusions associated with metastatic dissemination.

Conclusions

CA-4 effectively impairs multiple cancer cell functions related to metastatic progression, including proliferation, migration, cytoskeletal organization, and McTN formation. These findings highlight the potential of CA-4 as a microtubule-targeting agent with anti-metastatic activity, particularly in circulating tumor cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplastic Cells, CirculatingStilbenesAntineoplastic Agents, PhytogenicNeoplasmsHumansCell MovementCell Line, TumorCell SurvivalMDA-MB-231 CellsCell ProliferationFemale

Stichwörter der Autor:innen

Combretastatin A-4circulating tumor cellsmetastasismicrotentaclesmicrotubules

Substanzen

StilbenesfosbretabulinAntineoplastic Agents, Phytogenic

Autor:innen und Institutionen

  • Laboratory of Biochemistry/Metastatic Signaling, Section of Genetics, Cell Biology and Development, Department of Biology, University of Patras, University Campus, Patras, Greece.
  • Synthetic Organic Chemistry Laboratory, Department of Chemistry, University of Patras, University Campus, Patras, Greece.
  • Department of Pharmacology and Physiology, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Laboratory of Rare Human Circulating Cells and Liquid Biopsy (LCCRH), University Medical Centre of Montpellier, Montpellier, France.
  • CREEC, MIVEGEC, University of Montpellier, CNRS, IRD, Montpellier, France.
  • European Liquid Biopsy Society (ELBS), Hamburg, Germany.

Zitieren

APA

Papakonstantinou, D., Vardas, V., Varouhaki, D. M., Kotzamouratoglou, A., Mangani, K., Ju, J. A., Alix-Panabières, C., Martin, S. S., Athanassopoulos, C. M., & Kallergi, G. (2026). The Impact of Combretastatin A-4 on Cancer Cells and Circulating Tumor Cells (CTCs): A Multi-Assay Approach. Oncology Research. https://doi.org/10.32604/or.2026.085665

Vancouver

Papakonstantinou D, Vardas V, Varouhaki DM, Kotzamouratoglou A, Mangani K, Ju JA, et al. The Impact of Combretastatin A-4 on Cancer Cells and Circulating Tumor Cells (CTCs): A Multi-Assay Approach. Oncology Research. 2026. doi:10.32604/or.2026.085665

BibTeX
@article{Papakonstantinou2026,
  author = {Papakonstantinou, Dimitrios and Vardas, Vasileios and Varouhaki, Despoina M and Kotzamouratoglou, Aikaterini and Mangani, Karolina and Ju, Julia A and Alix-Panabières, Catherine and Martin, Stuart S and Athanassopoulos, Constantinos M and Kallergi, Galatea},
  title = {The Impact of Combretastatin A-4 on Cancer Cells and Circulating Tumor Cells (CTCs): A Multi-Assay Approach},
  journal = {Oncology Research},
  year = {2026},
  doi = {10.32604/or.2026.085665}
}
Kostenlos starten →